Cargando…

COVID-19: a case for inhibiting IL-17?

IL-17 and IL-17 receptor inhibitors boast an impressive safety history and are widely available. Here, we argue that targeting IL-17 is immunologically plausible as a strategy to prevent acute respiratory distress syndrome (ARDS) in coronavirus disease 2019 (COVID-19) and discuss why we think that a...

Descripción completa

Detalles Bibliográficos
Autores principales: Pacha, Omar, Sallman, Mary Alice, Evans, Scott E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194244/
https://www.ncbi.nlm.nih.gov/pubmed/32358580
http://dx.doi.org/10.1038/s41577-020-0328-z